Simulations Plus Inc. (SD3)
Munich
Closed
Sep 11, 2026
Day's Range
15.9052 wk Range
9.80Overview - SD3 - Simulations Plus Inc.
Key Statistics
Valuation
Enterprise Value
-30.23M
P/E (Trailing)
‪-4.93‬
PEG Ratio
‪0.04‬
Price / Book
‪2.31‬
EV / EBITDA
‪-0.33‬
Profitability
Gross Margin
‪69.11%‬
Profit Margin
‪58.37%‬
Operating Margin
‪8.19%‬
Return on Assets
‪-49.05%‬
Return on Equity
‪-51.85%‬
Ownership
Shares Outstanding
20.21M
Price stats
50-Day Avg
‪15.97‬
200-Day Avg
‪13.51‬
Peers - SD3 - Simulations Plus Inc.
Peer Comparison
Compared with companies in Health Information Services listed on Munich.
- SD3MunichSimulations Plus Inc.+35.22%52-week change-4.94P/E (Trailing)‪58.37%‬Profit Margin
- 0NI0MunichLogicMark, Inc.+99.87%52-week change-122.29P/E (Trailing)‪-49.64%‬Profit Margin
- P990MunichCodeLab Capital AS+55.24%52-week change-0.47P/E (Trailing)‪-51.83%‬Profit Margin
- 1KJMunich10x Genomics Inc.+81.29%52-week change-166.43P/E (Trailing)‪69.05%‬Profit Margin
- UY00MunichTripsitter Clinic Ltd.+45.55%52-week change—P/E (Trailing)—Profit Margin
- 4KLMunichUBERDOC Health Technologies Corp.+32.63%52-week change—P/E (Trailing)—Profit Margin
- I82MunichCarlsmed Inc.+29.78%52-week change-6.42P/E (Trailing)‪75.31%‬Profit Margin
Profile Summary - SD3 - Simulations Plus Inc.
About
Simulations Plus Inc. is a healthcare technology company that develops modeling and simulation software and consulting services for the pharmaceutical, biotechnology, and life sciences industries. The company’s products help customers support drug discovery, preclinical research, clinical development, regulatory…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
